AIIMS chief warns CT scan in mild Covid cases may do more harm than good

The AIIMS chief on Monday warned against rushing for CT scan in cases of mild COVID-19, saying it has side effects and can end up doing more harm than good.

Randeep Guleria, AIIMS director
Randeep Guleria, AIIMS director
Press Trust of India New Delhi
3 min read Last Updated : May 03 2021 | 7:31 PM IST

The AIIMS chief on Monday warned against rushing for CT scan in cases of mild COVID-19, saying it has side effects and can end up doing more harm than good.

Stressing that there is no need for doing CT scans in mild COVID cases, AIIMS Director Dr Randeep Guleria at a press conference said that many people are opting for the test the moment they find out they are positive for COVID-19 and added that misuse of CT scans and biomarkers may cause damage.

"One CT scan is equivalent to 300 to 400 chest x-rays. According to data, repeated CT scans in younger age groups increase the risk of cancer in later life. Exposing yourself to radiation again and again may cause damage. So, there is no point in doing CT scan in mild COVID-19 if the oxygen saturation is normal," Guleria said.

Even in mild illness and according to a study, even in asymptomatic cases, a CT scan may show patches which go away on their own without treatment, he said.

He advised that CT scans should be done in cases of moderate disease, when hospitalised. "Andif there is a doubt, one should opt for a chest x-ray," he said.

Guleria further said that several blood tests for biomarkers are also not needed in mild illness or in home isolation if the oxygen saturation is fine, fever is not high and there are no other symptoms.

"As this will cause panic. These biomarkers are acute phase reactants and they increase even when there is some normal injury and toothache, it does not show that the COVID-19 disease has become severe. This causes more damage. Reliance on these tests can lead to over treatment," he said.

He said that clinical management guidelines are clear that people with mild illness need no medicine. Based on limited data, one can take ivermectin or hydroxychloroquine but there is no need to take too many medicines, he advised.

"Some patients take steroids in the early part of the disease which increases viral replication. Taking high dose steroids in mild cases may lead to severe viral pneumonia. Steroids should be taken in moderate stage and as advised by doctors," he said.

Falling oxygen saturation (below 93), excessive fatigue or chest pain are warning signs indicating that a patient in home isolation may need hospitalisation. Thus, such patients should stay in touch with a doctor and high-risk group people having comorbidities also need to take special care, he said.

Guleria further said that in moderate illnesses three types of treatment --oxygen therapy, steroids and anticoagulants -- are effective and are the main treatment strategy.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: May 03 2021 | 7:25 PM IST

Next Story